ClinVar Genomic variation as it relates to human health
NM_001018005.2(TPM1):c.114+2T>C
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001018005.2(TPM1):c.114+2T>C
Variation ID: 370039 Accession: VCV000370039.2
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 15q22.2 15: 63042945 (GRCh38) [ NCBI UCSC ] 15: 63335144 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Jun 25, 2017 Jun 25, 2017 - HGVS
- ... more HGVS ... less HGVS
- Protein change
- -
- Other names
-
TPM1
- Canonical SPDI
- NC_000015.10:63042944:T:C
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
-
Variation affecting splicing function of RNA; Variation Ontology [ VariO:0397]
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
TPM1 | No evidence available | No evidence available |
GRCh38 GRCh37 |
855 | 903 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Likely pathogenic (1) |
no assertion criteria provided
|
- | RCV000491976.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(-)
|
no assertion criteria provided
Method: in vitro
|
Tetralogy of Fallot
(Autosomal dominant inheritance)
Affected status: not applicable
Allele origin:
not applicable
|
Laboratory of Research in Genomics, Genetics and Bioinformatics, Hospital Infantil de Mexico Federico Gomez
Study: TPM1 mutations in CHD
Accession: SCV000321072.1 First in ClinVar: Jun 25, 2017 Last updated: Jun 25, 2017 |
Sex: female
Result:
Genomic DNA was obtained from patient A with a heterozygous splicing-donor site mutation at exon1-intron1 (as described above). DNA was also obtained from a control subject. PCR products were obtained and subcloned into pcDNA3.1(+) (Invitrogen). Clones were sequenced to identify a splice-site mutation, and wildtype constructs. COS7 cells were transfected with each construct using Polyfect Transfection reagent (Qiagen) and incubated for 48 h. Following RNA extraction, reverse transcription was performed using 0.5 µg of RNA per reaction. A primer pair specific to TPM1 5’ upstream and exon2a were used to detect TPM1 products. To assess the functional consequence of a novel TPM1 spice site mutation, two constructs were created, spanning the 5’ upstream region of TPM1 to exon 2a, using patient A and a control’s genomic DNA (Fig. 1E). Constructs contained either the IVS1+2T>C splice site mutation, or wild-type TPM1. RT-PCR showed that the wild-type produced a transcribed TPM1 product of 307 bp whilst no concurrent product was seen for the splice-site mutation construct .
|
Germline Functional Evidence
Functional
Help
The functional consequence of the variant, based on experimental evidence and provided by the submitter. consequence |
Method
Help
A brief description of the method used to determine the functional consequence of the variant. A citation for the method is included, when provided by the submitter. |
Result
Help
A brief description of the result of this method for this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting functional evidence for the germline classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
---|---|---|---|---|
Variation affecting splicing function of RNA
|
|
|
Laboratory of Research in Genomics, Genetics and Bioinformatics, Hospital Infantil de Mexico Federico Gomez
Study: TPM1 mutations in CHD Accession: SCV000321072.1
|
|
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Tropomyosin 1: Multiple roles in the developing heart and in the formation of congenital heart defects. | England J | Journal of molecular and cellular cardiology | 2017 | PMID: 28359939 |
Text-mined citations for rs1114167357 ...
HelpRecord last updated Jun 23, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.